These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9241006)

  • 1. Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial.
    Rickels K; Schweizer E; DeMartinis N; Mandos L; Mercer C
    J Clin Psychopharmacol; 1997 Aug; 17(4):272-7. PubMed ID: 9241006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone: anxiolytic?
    Pecknold JC; Familamiri P; Chang H; Wilson R; Alarcia J; McClure DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):639-42. PubMed ID: 2868495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study.
    Fontaine R; Beaudry P; Beauclair L; Chouinard G
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):189-97. PubMed ID: 2888159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis.
    Lapierre YD; Tremblay A; Gagnon A; Monpremier P; Berliss H; Oyewumi LK
    J Clin Psychiatry; 1982 Sep; 43(9):372-4. PubMed ID: 6126475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder.
    Ansseau M; Olié JP; von Frenckell R; Jourdain G; Stehle B; Guillet P
    Psychopharmacology (Berl); 1991; 104(4):439-43. PubMed ID: 1685793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment, discontinuation, and psychomotor effects of diazepam in women with generalized anxiety disorder.
    Pourmotabbed T; Mcleod DR; Hoehn-Saric R; Hipsley P; Greenblatt DJ
    J Clin Psychopharmacol; 1996 Jun; 16(3):202-7. PubMed ID: 8784650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a putative anxiolytic agent: ipsapirone.
    Borison RL; Albrecht JW; Diamond BI
    Psychopharmacol Bull; 1990; 26(2):207-10. PubMed ID: 1978371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gepirone in the treatment of major depression.
    Jenkins SW; Robinson DS; Fabre LF; Andary JJ; Messina ME; Reich LA
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):77S-85S. PubMed ID: 1973942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder.
    Rickels K; DeMartinis N; Aufdembrinke B
    J Clin Psychopharmacol; 2000 Feb; 20(1):12-8. PubMed ID: 10653203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse prevention with gepirone ER in outpatients with major depression.
    Keller MB; Ruwe FJ; Janssens CJ; Sitsen JM; Jokinen R; Janczewski J
    J Clin Psychopharmacol; 2005 Feb; 25(1):79-84. PubMed ID: 15643103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder.
    Boyer WF; Feighner JP
    Int Clin Psychopharmacol; 1993; 8(3):173-6. PubMed ID: 7903326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buspirone: multicenter efficacy study.
    Wheatley D
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gepirone in anxiety: a pilot study.
    Csanalosi I; Schweizer E; Case WG; Rickels K
    J Clin Psychopharmacol; 1987 Feb; 7(1):31-3. PubMed ID: 2880873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketazolam and diazepam in anxiety: a controlled study.
    Rickels K; Csanalosi I; Greisman P; Mirman MJ; Morris RJ; Weise CC; Weiss G
    J Clin Pharmacol; 1980 Oct; 20(10):581-9. PubMed ID: 6108335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder.
    Cutler NR; Hesselink JM; Sramek JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 May; 18(3):447-63. PubMed ID: 7915845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function.
    Lucki I; Rickels K; Giesecke MA; Geller A
    Br J Clin Pharmacol; 1987 Feb; 23(2):207-11. PubMed ID: 2881573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the side-effect profile of buspirone.
    Newton RE; Marunycz JD; Alderdice MT; Napoliello MJ
    Am J Med; 1986 Mar; 80(3B):17-21. PubMed ID: 2870641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.